About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01543308

The Alteration of HDL Protein Composition in Patients With Coronary Heart Disease Before and After Statins Treatment

The protein composition of HDL is complicated. The investigators have identified 40 distinct proteins associated with HDL by proteomics technology, and these proteins have been confirmed to be related...

Lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Collaborators

Ministry of Science and Technology of the People´s Republic of China
Beijing Proteome Research Center

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Angiographic evidence of coronary artery disease, and no lipid-lowering therapy in the past 2 weeks for treatment group;

Exclusion Criteria

•Use of potent lipid-lowering therapy for more than 2 weeks; myocardial infarction or percutaneous coronary intervention in the past 6 months; severe congestive heart failure, valvular heart disease and other non-coronary heart disease cardiovascular disease; liver or renal dysfunction; connective tissue disease; infection, Malignancy; and other conditions that physicians considered inappropriate to the study.

Related studies

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

NCT07165678 · Coronary Heart Disease

RECRUITINGPhase 1/2

A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease

NCT07493603 · Coronary Heart Disease, Coronary Artery Disease, and more

Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

NCT07451873 · Coronary Heart Disease

Clinical Outcomes of Patients With Coronary Artery Disease

NCT06216847 · Coronary Heart Disease (CHD)

Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 20, 2013Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment400

Start dateFeb 2012

Last updatedMay 20, 2013

Condition

Coronary Heart Disease

Locations shown

Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, FuWai Hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 20, 2013Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions